Skip to main content
Top

16-12-2023 | Heart Surgery | Original Article

Serum tau protein and myelin basic protein in pediatric patients with congenital heart defects undergoing cardiac surgery: preliminary assessment as novel neuromarkers of brain injury

Authors: Lacramioara Eliza Chiperi, Cristina Tecar, Adina Huţanu

Published in: Irish Journal of Medical Science (1971 -)

Login to get access

Abstract

Introduction

Neurological impairment is a big concern in the development of patients with congenital heart defects (CHD). A number of neuromarkers have been studied in search of a diagnostic or prognostic marker for brain injury during the vulnerable perioperative period. Our aim was to assess two novel neuromarkers, myelin basic protein (MBP) and protein Tau (pTau), as diagnostic markers for brain injury in perioperative period in children with CHD.

Methods

Forty patients were enrolled and dichotomized based on peripheric oxygen saturation in cyanotic and non-cyanotic group. Blood samples were collected preoperative, after the induction of anesthesia, and in postoperative day 1. Neuromarker concentrations were measured using commercially available ELISA kits.

Results

Neuromarkers’ values were increased postoperative, with statistical significance reached only in non-cyanotic group (p < 0.0001). A significant positive correlation was observed between preoperatory MBP and albumin level, hemoglobin level, height, and weight of patients. Association with cerebral saturations were analyzed by a coefficient defined as ≥ 20% reduction in cerebral saturation measured by near-infrared spectroscopy during perioperative period. An acceptable predicting model was observed with pTau in cyanotic group (AUC = 0.7).

Conclusion

We evaluated MBP and pTau as potential biomarkers of brain injury in children with CHD undergoing cardiac surgery. Elevated postoperative pTau and MBP concentrations were observed in both groups. Elevated pTau values were associated with perioperative hypoxemia.
Literature
1.
go back to reference Go AS, Mozaffarian D, Roger VL et al (2014) Heart disease and stroke statistics – 2014 update: a report from the American heart association. Circulation 129(3):e28–e292PubMed Go AS, Mozaffarian D, Roger VL et al (2014) Heart disease and stroke statistics – 2014 update: a report from the American heart association. Circulation 129(3):e28–e292PubMed
2.
go back to reference Pironkova RP, Giamelli J, Seiden H et al (2017) Brain injury with systemic inflammation in newborns with congenital heart disease undergoing heart surgery. Exp Ther Med 14(1):228–238CrossRefPubMedPubMedCentral Pironkova RP, Giamelli J, Seiden H et al (2017) Brain injury with systemic inflammation in newborns with congenital heart disease undergoing heart surgery. Exp Ther Med 14(1):228–238CrossRefPubMedPubMedCentral
3.
go back to reference Oster ME, Lee KA, Honein MA et al (2013) Temporal trends in survival among infants with critical congenital heart defects. Pediatrics 131(5):e1502–e1508CrossRefPubMed Oster ME, Lee KA, Honein MA et al (2013) Temporal trends in survival among infants with critical congenital heart defects. Pediatrics 131(5):e1502–e1508CrossRefPubMed
5.
go back to reference Marino BS, Lipkin PH, Newburger JW et al (2012) American heart association congenital heart defects committee, council on cardiovascular disease in the young, council on cardiovascular nursing, and stroke council, neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American heart association. Circulation 126(9):1143–1172CrossRefPubMed Marino BS, Lipkin PH, Newburger JW et al (2012) American heart association congenital heart defects committee, council on cardiovascular disease in the young, council on cardiovascular nursing, and stroke council, neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American heart association. Circulation 126(9):1143–1172CrossRefPubMed
6.
go back to reference Dimitropoulos A, McQuillen PS, Sethi V et al (2013) Brain injury and development in newborns with critical congenital heart disease. Neurology 81(3):241–248CrossRefPubMedPubMedCentral Dimitropoulos A, McQuillen PS, Sethi V et al (2013) Brain injury and development in newborns with critical congenital heart disease. Neurology 81(3):241–248CrossRefPubMedPubMedCentral
7.
go back to reference Graham EM, Martin RH, Atz AM et al (2019) Association of intraoperative circulating-brain injury biomarker and neurodevelopmental outcomes at 1 year among neonates who have undergone cardiac surgery. J Thorac Cardiovasc Surg 157(5):1996–2002CrossRefPubMedPubMedCentral Graham EM, Martin RH, Atz AM et al (2019) Association of intraoperative circulating-brain injury biomarker and neurodevelopmental outcomes at 1 year among neonates who have undergone cardiac surgery. J Thorac Cardiovasc Surg 157(5):1996–2002CrossRefPubMedPubMedCentral
8.
go back to reference Chiperi LE, Tecar C, Toganel R (2023) Neuromarkers which can predict neurodevelopmental impairment among children with congenital heart defects after cardiac surgery: a systematic literature review. Dev Neurorehabil 26(3):206–215CrossRefPubMed Chiperi LE, Tecar C, Toganel R (2023) Neuromarkers which can predict neurodevelopmental impairment among children with congenital heart defects after cardiac surgery: a systematic literature review. Dev Neurorehabil 26(3):206–215CrossRefPubMed
9.
go back to reference Trakas E, Domnina Y, Panigrahy A et al (2017) Serum neuronal biomarkers in neonates with congenital heart disease undergoing cardiac surgery. Pediatr Neurol 72:56–61CrossRefPubMed Trakas E, Domnina Y, Panigrahy A et al (2017) Serum neuronal biomarkers in neonates with congenital heart disease undergoing cardiac surgery. Pediatr Neurol 72:56–61CrossRefPubMed
10.
go back to reference Sanchez-de-Toledo J, Chrysostomou C, Munoz R et al (2014) Cerebral regional oxygen saturation and serum neuromarkers for the prediction of adverse neurologic outcome in pediatric cardiac surgery. Neurocrit Care 21(1):133–139CrossRefPubMed Sanchez-de-Toledo J, Chrysostomou C, Munoz R et al (2014) Cerebral regional oxygen saturation and serum neuromarkers for the prediction of adverse neurologic outcome in pediatric cardiac surgery. Neurocrit Care 21(1):133–139CrossRefPubMed
11.
go back to reference Schmitt B, Bauersfeld U, Schmid ER et al (1998) Serum and CSF levels of neuron-specific enolase (NSE) in cardiac surgery with cardiopulmonary bypass: a marker of brain injury? Brain Dev 20(7):536–539CrossRefPubMed Schmitt B, Bauersfeld U, Schmid ER et al (1998) Serum and CSF levels of neuron-specific enolase (NSE) in cardiac surgery with cardiopulmonary bypass: a marker of brain injury? Brain Dev 20(7):536–539CrossRefPubMed
12.
go back to reference Abella R, Varrica A, Satriano A et al (2015) Biochemical markers for brain injury monitoring in children with or without congenital heart diseases. CNS Neurol Disord Drug Targets 14(1):12–23CrossRefPubMed Abella R, Varrica A, Satriano A et al (2015) Biochemical markers for brain injury monitoring in children with or without congenital heart diseases. CNS Neurol Disord Drug Targets 14(1):12–23CrossRefPubMed
13.
go back to reference Robertson DR, Justo RN, Burke CJ et al (2014) Perioperative predictors of developmental outcome following cardiac surgery in infancy. Cardiol Young 14(4):389–395CrossRef Robertson DR, Justo RN, Burke CJ et al (2014) Perioperative predictors of developmental outcome following cardiac surgery in infancy. Cardiol Young 14(4):389–395CrossRef
14.
go back to reference Bar-Yosef O, Greidinger D, Iskilova M et al (2018) Neurological deficit is predicted by S100B in children after cardiac surgery. Clin Chim Acta 481:56–60 Bar-Yosef O, Greidinger D, Iskilova M et al (2018) Neurological deficit is predicted by S100B in children after cardiac surgery. Clin Chim Acta 481:56–60
15.
go back to reference Lardner D, Davidson A, McKenzie I, Cochrane A (2004) Delayed rises in serum S100B levels and adverse neurological outcome in infants and children undergoing cardiopulmonary bypass. Paediatr Anaesth 14(6):495–500CrossRefPubMed Lardner D, Davidson A, McKenzie I, Cochrane A (2004) Delayed rises in serum S100B levels and adverse neurological outcome in infants and children undergoing cardiopulmonary bypass. Paediatr Anaesth 14(6):495–500CrossRefPubMed
16.
go back to reference Vergine M, Vedovelli L, Simonato M et al (2021) Perioperative glial fibrillary acidic protein is associated with long-term neurodevelopment outcome of infants with congenital heart disease. Children (Basel) 8:655PubMed Vergine M, Vedovelli L, Simonato M et al (2021) Perioperative glial fibrillary acidic protein is associated with long-term neurodevelopment outcome of infants with congenital heart disease. Children (Basel) 8:655PubMed
17.
go back to reference Vedovelli L, Padalino M, Suppiej A et al (2018) Cardiopulmonary-bypass glial fibrillary acidic protein correlates with neurocognitive skills. Ann Thorac Surg 106(3):792–798CrossRefPubMed Vedovelli L, Padalino M, Suppiej A et al (2018) Cardiopulmonary-bypass glial fibrillary acidic protein correlates with neurocognitive skills. Ann Thorac Surg 106(3):792–798CrossRefPubMed
18.
go back to reference Lee T, Chikkabyrappa SM, Reformina D et al (2018) Ubiquitin C-terminal hydrolase 1 and phosphorylated axonal neurofilament heavy chain in infants undergoing cardiac surgery: preliminary assessment as potential biomarkers of brain injury. World J Pediatr Congenit Heart Surg 9(4):412–418CrossRefPubMed Lee T, Chikkabyrappa SM, Reformina D et al (2018) Ubiquitin C-terminal hydrolase 1 and phosphorylated axonal neurofilament heavy chain in infants undergoing cardiac surgery: preliminary assessment as potential biomarkers of brain injury. World J Pediatr Congenit Heart Surg 9(4):412–418CrossRefPubMed
19.
go back to reference Gessler P, Pretre R, Hohl V et al (2004) CXC-chemokine stimulation of neutrophils correlates with plasma levels of myeloperoxidase and lactoferrin and contributes to clinical outcome after pediatric cardiac surgery. Shock 22(6):513–520CrossRefPubMed Gessler P, Pretre R, Hohl V et al (2004) CXC-chemokine stimulation of neutrophils correlates with plasma levels of myeloperoxidase and lactoferrin and contributes to clinical outcome after pediatric cardiac surgery. Shock 22(6):513–520CrossRefPubMed
20.
go back to reference Bembea MM, Rizkalla N, Freedy J et al (2015) Plasma biomarkers of brain injury as diagnostic tools and outcome predictors after extracorporeal membrane oxygenation. Crit Care Med 43(10):2202–2211CrossRefPubMed Bembea MM, Rizkalla N, Freedy J et al (2015) Plasma biomarkers of brain injury as diagnostic tools and outcome predictors after extracorporeal membrane oxygenation. Crit Care Med 43(10):2202–2211CrossRefPubMed
21.
go back to reference Mörtberg E, Zetterberg H, Nordmark J et al (2011) Plasma tau protein in comatose patients after cardiac arrest treated with therapeutic hypothermia. Acta Anaesthesiol Scand 55(9):1132–1138CrossRefPubMed Mörtberg E, Zetterberg H, Nordmark J et al (2011) Plasma tau protein in comatose patients after cardiac arrest treated with therapeutic hypothermia. Acta Anaesthesiol Scand 55(9):1132–1138CrossRefPubMed
22.
go back to reference Binder LI, Frankfurter A, Rebhun LI (1985) The distribution of tau in the mammalian central nervous system. J Cell Biol 101(4):1371–1378CrossRefPubMed Binder LI, Frankfurter A, Rebhun LI (1985) The distribution of tau in the mammalian central nervous system. J Cell Biol 101(4):1371–1378CrossRefPubMed
23.
go back to reference Randall J, Mörtberg E, Provuncher GK et al (2013) Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: results of a pilot study. Resuscitation 84(3):351–356CrossRefPubMed Randall J, Mörtberg E, Provuncher GK et al (2013) Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: results of a pilot study. Resuscitation 84(3):351–356CrossRefPubMed
24.
go back to reference Li R, Lee JK, Govindan RB et al (2023) Plasma biomarkers of evolving encephalopathy and brain injury in neonates with hypoxic-ischemic encephalopathy. J Pediatr 252:146–153CrossRefPubMed Li R, Lee JK, Govindan RB et al (2023) Plasma biomarkers of evolving encephalopathy and brain injury in neonates with hypoxic-ischemic encephalopathy. J Pediatr 252:146–153CrossRefPubMed
25.
go back to reference Liliang PC, Liang CL, Weng HC et al (2010) Tau proteins in serum predict outcome after severe traumatic brain injury. J Surg Res 160(2):302–307CrossRefPubMed Liliang PC, Liang CL, Weng HC et al (2010) Tau proteins in serum predict outcome after severe traumatic brain injury. J Surg Res 160(2):302–307CrossRefPubMed
26.
go back to reference Hossain I, Blennow K, Posti JP, Zetterberg H (2022) Tau as a fluid biomarker of concussion and neurodegeneration. Concussion (London, England) 7(2):CNC98 Hossain I, Blennow K, Posti JP, Zetterberg H (2022) Tau as a fluid biomarker of concussion and neurodegeneration. Concussion (London, England) 7(2):CNC98
27.
go back to reference Castellani RJ, Perry G (2019) Tau biology, tauopathy, traumatic brain injury, and diagnostic challenges. J Alzheimer’s Dis 67(2):447–467 Castellani RJ, Perry G (2019) Tau biology, tauopathy, traumatic brain injury, and diagnostic challenges. J Alzheimer’s Dis 67(2):447–467
28.
go back to reference Nakamura K, Greenwood A, Binder L et al (2012) Proline isomer-specific antibodies reveal the early pathogenic tau conformation in Alzheimer’s disease. Cell 149(1):232–244CrossRefPubMedPubMedCentral Nakamura K, Greenwood A, Binder L et al (2012) Proline isomer-specific antibodies reveal the early pathogenic tau conformation in Alzheimer’s disease. Cell 149(1):232–244CrossRefPubMedPubMedCentral
29.
go back to reference Fink EL, Berger RP, Clark RS et al (2014) Serum biomarkers of brain injury to classify outcome after pediatric cardiac arrest. Crit Care Med 42(3):664–674CrossRefPubMedPubMedCentral Fink EL, Berger RP, Clark RS et al (2014) Serum biomarkers of brain injury to classify outcome after pediatric cardiac arrest. Crit Care Med 42(3):664–674CrossRefPubMedPubMedCentral
30.
go back to reference Sandler SJ, Figaji AA, Adelson PD (2010) Clinical applications of biomarkers in pediatric traumatic brain injury. Child’s nervous system 26(2):205–213CrossRefPubMed Sandler SJ, Figaji AA, Adelson PD (2010) Clinical applications of biomarkers in pediatric traumatic brain injury. Child’s nervous system 26(2):205–213CrossRefPubMed
31.
go back to reference Thomas DG, Palfreyman JW, Ratcliffe JG (1978) Serum-myelin-basic-protein assay in diagnosis and prognosis of patients with head injury. Lancet 1:113–115CrossRefPubMed Thomas DG, Palfreyman JW, Ratcliffe JG (1978) Serum-myelin-basic-protein assay in diagnosis and prognosis of patients with head injury. Lancet 1:113–115CrossRefPubMed
33.
go back to reference Graham EM, Everett AD, Delpech JC, Northington FJ (2018) Blood biomarkers for evaluation of perinatal encephalopathy: state of the art. Curr Opin pediatr 30(2):199–203CrossRefPubMedPubMedCentral Graham EM, Everett AD, Delpech JC, Northington FJ (2018) Blood biomarkers for evaluation of perinatal encephalopathy: state of the art. Curr Opin pediatr 30(2):199–203CrossRefPubMedPubMedCentral
34.
go back to reference Lv H, Wang Q, Wu S et al (2015) Neonatal hypoxic ischemic encephalopathy-related biomarkers in serum and cerebrospinal fluid. Clinica chimica acta. International J Clin Chem 450:282–297 Lv H, Wang Q, Wu S et al (2015) Neonatal hypoxic ischemic encephalopathy-related biomarkers in serum and cerebrospinal fluid. Clinica chimica acta. International J Clin Chem 450:282–297
35.
go back to reference Wang Q, Lv H, Wu S et al (2022) Effect of hypothermia on serum myelin basic protein and tumor necrosis factor-α in neonatal hypoxic-ischemic encephalopathy. Am J Perinatol 39(12):1367–1374CrossRefPubMed Wang Q, Lv H, Wu S et al (2022) Effect of hypothermia on serum myelin basic protein and tumor necrosis factor-α in neonatal hypoxic-ischemic encephalopathy. Am J Perinatol 39(12):1367–1374CrossRefPubMed
36.
go back to reference Schiller O, Goldshmid O, Mowassi S et al (2020) The utility of albumin level as a marker of postoperative course in infants undergoing repair of congenital heart disease. Pediatr Cardiol 41(5):939–946CrossRefPubMed Schiller O, Goldshmid O, Mowassi S et al (2020) The utility of albumin level as a marker of postoperative course in infants undergoing repair of congenital heart disease. Pediatr Cardiol 41(5):939–946CrossRefPubMed
37.
go back to reference Van Beek DEC, Van Der Horst ICC, De Geus AF et al (2018) Albumin, a marker for post-operative myocardial damage in cardiac surgery. J Crit Care 47:55–60CrossRefPubMed Van Beek DEC, Van Der Horst ICC, De Geus AF et al (2018) Albumin, a marker for post-operative myocardial damage in cardiac surgery. J Crit Care 47:55–60CrossRefPubMed
38.
go back to reference Leite HP, da Silva AVR, de Oliveira Iglesias SB, Nogueira PCK (2016) Serum albumin is an independent predictor of clinical outcomes in critically ill children. Pediatr Crit Care Med 17(2):e50–e57 Leite HP, da Silva AVR, de Oliveira Iglesias SB, Nogueira PCK (2016) Serum albumin is an independent predictor of clinical outcomes in critically ill children. Pediatr Crit Care Med 17(2):e50–e57
39.
go back to reference Kapoor P, Narula J, Chowdhury U et al (2016) Serum albumin perturbations in cyanotics after cardiac surgery: patterns and predictions. Ann Card Anaesth 19:300CrossRefPubMedPubMedCentral Kapoor P, Narula J, Chowdhury U et al (2016) Serum albumin perturbations in cyanotics after cardiac surgery: patterns and predictions. Ann Card Anaesth 19:300CrossRefPubMedPubMedCentral
40.
go back to reference Hansen JH, Kissner L, Logoteta J et al (2019) S100B and its relation to cerebral oxygenation in neonates and infants undergoing surgery for congenital heart disease. Congenit Heart Dis 14(3):427–437CrossRefPubMed Hansen JH, Kissner L, Logoteta J et al (2019) S100B and its relation to cerebral oxygenation in neonates and infants undergoing surgery for congenital heart disease. Congenit Heart Dis 14(3):427–437CrossRefPubMed
41.
go back to reference Kurth CD, Levy WJ, McCann J (2002) Near-infrared spectroscopy cerebral oxygen saturation thresholds for hypoxia-ischemia in piglets. J Cereb Blood flow Metab: Offic J Int Soc Cereb Blood Flow Metab 22(3):335–341CrossRefPubMed Kurth CD, Levy WJ, McCann J (2002) Near-infrared spectroscopy cerebral oxygen saturation thresholds for hypoxia-ischemia in piglets. J Cereb Blood flow Metab: Offic J Int Soc Cereb Blood Flow Metab 22(3):335–341CrossRefPubMed
42.
go back to reference Dietrick B, Molloy E, Massaro AN et al (2020) Plasma and cerebrospinal fluid candidate biomarkers of neonatal encephalopathy severity and neurodevelopmental outcomes. J Pediatr 226:71–79CrossRefPubMed Dietrick B, Molloy E, Massaro AN et al (2020) Plasma and cerebrospinal fluid candidate biomarkers of neonatal encephalopathy severity and neurodevelopmental outcomes. J Pediatr 226:71–79CrossRefPubMed
43.
go back to reference Massaro AN, Wu YW, Bammler TK et al (2018) Plasma biomarkers of brain injury in neonatal hypoxic-ischemic encephalopathy. J Pediatr 194:67–75CrossRefPubMed Massaro AN, Wu YW, Bammler TK et al (2018) Plasma biomarkers of brain injury in neonatal hypoxic-ischemic encephalopathy. J Pediatr 194:67–75CrossRefPubMed
Metadata
Title
Serum tau protein and myelin basic protein in pediatric patients with congenital heart defects undergoing cardiac surgery: preliminary assessment as novel neuromarkers of brain injury
Authors
Lacramioara Eliza Chiperi
Cristina Tecar
Adina Huţanu
Publication date
16-12-2023
Publisher
Springer International Publishing
Published in
Irish Journal of Medical Science (1971 -)
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-023-03582-5
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.